Search Results

You are looking at 51 - 60 of 899 items for :

  • "metastases" x
  • Refine by Access: All x
Clear All
Full access

Hitting the Right Spot: Advances in the Treatment of NSCLC With Uncommon EGFR Mutations

Joshua K. Sabari, John V. Heymach, and Beth Sandy

with central nervous system metastases. Rates of grade ≥3 adverse events were lower in patients treated with osimertinib versus platinum-pemetrexed chemotherapy. The phase III, double-blind FLAURA trial of osimertinib randomized 556 patients with

Full access

Synchronous Metastatic Rectal Cancer Completely Resected After Multidisciplinary Planning and Treatment: A Case Report

Hans F. Schoellhammer, Gagandeep Singh, and Lucille Leong

Presentation A 48-year-old man presented to City of Hope Comprehensive Cancer Center (COHCC) with a diagnosis of rectal adenocarcinoma and synchronous liver metastases. For 1 year, the patient had been experiencing intermittent hematochezia, thinning stool

Full access

Central Nervous System Cancers, Version 2.2014

Louis Burt Nabors, Jana Portnow, Mario Ammirati, Henry Brem, Paul Brown, Nicholas Butowski, Marc C. Chamberlain, Lisa M. DeAngelis, Robert A. Fenstermaker, Allan Friedman, Mark R. Gilbert, Jona Hattangadi-Gluth, Deneen Hesser, Matthias Holdhoff, Larry Junck, Ronald Lawson, Jay S. Loeffler, Paul L. Moots, Maciej M. Mrugala, Herbert B. Newton, Jeffrey J. Raizer, Lawrence Recht, Nicole Shonka, Dennis C. Shrieve, Allen K. Sills Jr, Lode J. Swinnen, David Tran, Nam Tran, Frank D. Vrionis, Patrick Yung Wen, Nicole R. McMillian, and Maria Ho

. Participation in clinical trials is especially encouraged. Overview Metastases to the brain are the most common intracranial tumors in adults and may occur up to 10 times more frequently than primary brain tumors. Population-based data reported that

Full access

NCCN Task Force Report: Bone Health in Cancer Care

Julie R. Gralow, J. Sybil Biermann, Azeez Farooki, Monica N. Fornier, Robert F. Gagel, Rashmi N. Kumar, Charles L. Shapiro, Andrew Shields, Matthew R. Smith, Sandy Srinivas, and Catherine H. Van Poznak

metastases given androgen deprivation therapy . J Urol 2002 ; 167 : 2361 – 2367 ; discussion 2367 . 133 Smith MR McGovern FJ Zietman AL . Pamidronate to prevent bone loss in men receiving gonadotropin releasing hormone agonist therapy for

Full access

Post-Chemoradiation Surgical Pathology Stage Can Customize the Surveillance Strategy in Patients With Esophageal Adenocarcinoma

Takashi Taketa, Kazuki Sudo, Arlene M. Correa, Roopma Wadhwa, Hironori Shiozaki, Elena Elimova, Maria-Claudia Campagna, Mariela A. Blum, Heath D. Skinner, Ritsuko U. Komaki, Jeffrey H. Lee, Manoop S. Bhutani, Brian R. Weston, David C. Rice, Stephen G. Swisher, Dipen M. Maru, Wayne L. Hofstetter, and Jaffer A. Ajani

patients had clinical stage II (39.0%) or III (51.7%) cancer. Of the 518 patients, 25 (4.8%) had M1a (celiac lymph node metastases) and were designated clinical stage IVa according to the AJCC 6th edition. 17 Type of Surgery Most of the patients (70

Full access

Small Cell Lung Cancer in Light/Never Smokers – A Role for Molecular Testing?

Gordon Taylor Moffat, Tao Wang, and Andrew G. Robinson

with mediastinal and pleural invasion ( Figure 1 ). Further staging identified metastases in the brain, liver, and bone, and a clinical stage of T4N3M1c, stage IVB. The patient had a history of early-stage invasive breast cancer treated with a

Full access

Full Spectrum: Efficacy and Toxicity of Immunotherapy in Metastatic Melanoma

Matthew Zibelman and Anthony J. Olszanski

months after initial dose of ipilimumab reveals a marked decrease in size and fludeoxyglucose-avidity of right neck mass and complete resolution of bilateral adrenal and liver metastases (representative images). Discussion This case

Full access

Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide

Kelly G. Paulson and Shailender Bhatia

is aggressive, and approximately 37% of patients have nodal or distant spread at presentation ( Figure 1B ); sentinel lymph node evaluation is thus frequently useful to identify subclinical nodal metastases. 4 , 6 Systemic radiologic staging is

Full access

Breast Cancer Diagnostics, Therapy, and Outcomes in Sub-Saharan Africa: A Population-Based Registry Study

Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt

ultrasounds and chest and bone radiographs were the most commonly used means of screening for metastases. The HRS was recorded for 17.5% of all women and for 27.5% of traced patients. Therapy Characteristics Therapy Received and Guideline Adherence In

Full access

Breast Cancer Diagnostics, Therapy, and Outcomes in Sub-Saharan Africa: A Population-Based Registry Study

Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt

were the most commonly used means of screening for metastases. The HRS was recorded for 17.5% of all women and for 27.5% of traced patients. Therapy Characteristics Therapy Received and Guideline Adherence In the population-based cohort, there